Treatment of Psoriatic Plaque on the Second Metatarsal
For a psoriatic plaque on the second metatarsal, initiate treatment with a combination product containing calcipotriene (vitamin D analogue) and betamethasone dipropionate (topical corticosteroid), which can be safely used for up to 52 weeks and is specifically recommended for palmoplantar psoriasis. 1
Primary Treatment Approach
The foot location (second metatarsal) classifies this as palmoplantar psoriasis, which requires potent topical therapy due to the thick skin in this area. The 2021 AAD-NPF guidelines provide Grade A recommendations for this clinical scenario:
First-Line Therapy
- Combination calcipotriene/betamethasone dipropionate is the optimal choice 1
- Grade A recommendation for combination vitamin D analogues with potent class II-III topical corticosteroids
- Can be used safely for up to 52 weeks without significant adverse events
- More effective than either agent alone
Alternative Regimens (if combination product unavailable)
- Weekday/weekend split regimen: Apply vitamin D analogue twice daily on weekdays, high-potency corticosteroid twice daily on weekends (Grade B recommendation) 1
- Morning/evening split: High-potency corticosteroid in morning, vitamin D analogue in evening (Grade B recommendation) 1
Additional Considerations for Palmoplantar Location
Adjunctive Keratolytic Therapy
For thick plaques on the foot, consider adding salicylic acid to enhance penetration of other topicals 2. However, critical caveat: Never apply salicylic acid simultaneously with calcipotriene—the acidic pH inactivates calcipotriene. Apply salicylic acid separately, allowing time between applications 1.
Alternative Topical Options
- Topical maxacalcitol (vitamin D analogue) can be considered as initial treatment specifically for palmoplantar psoriasis, though not available in the US 1
- Tazarotene 0.1% combined with medium- or high-potency corticosteroid for 8-16 weeks is another evidence-based option 1
- Reduces irritation when combined with corticosteroids
- Contraindicated in pregnancy—obtain negative pregnancy test 2 weeks before starting in women of childbearing age 1
Treatment Duration and Monitoring
- Initial treatment period: 4-12 weeks to assess response
- Long-term maintenance: Up to 52 weeks is safe with vitamin D/corticosteroid combinations 1
- Target response: Aim for at least 50-74% improvement in plaque elevation, scaling, and erythema 1
Common Pitfalls to Avoid
- Do not use low-potency corticosteroids on palmoplantar areas—the thick skin requires high-potency agents 2
- Avoid simultaneous salicylic acid and calcipotriene application 1
- Do not apply vitamin D analogues before phototherapy if patient is receiving UV treatment—apply after to avoid inactivation 1
- Do not prescribe tazarotene without pregnancy counseling in women of reproductive age 1
Adjunctive Measures
- Emollients should be used liberally as part of the treatment regimen to reduce itching and desquamation 2
- Consider occlusion techniques to enhance penetration in this thick-skinned area